Meridian Wealth Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $249K | Buy |
6,476
+305
| +5% | +$11.7K | 0.01% | 594 |
|
|
2025
Q1 | $239K | Sell |
6,171
-5,210
| -46% | -$202K | 0.01% | 565 |
|
|
2024
Q4 | $385K | Sell |
11,381
-2,255
| -17% | -$76.3K | 0.02% | 473 |
|
|
2024
Q3 | $557K | Sell |
13,636
-2,380
| -15% | -$97.3K | 0.03% | 390 |
|
|
2024
Q2 | $617K | Buy |
+16,016
| New | +$617K | 0.07% | 156 |
|
|
2024
Q1 | – | Sell |
-44,686
| Closed | -$1.66M | – | 332 |
|
|
2023
Q4 | $1.66M | Buy |
44,686
+38,211
| +590% | +$1.42M | 0.11% | 188 |
|
|
2023
Q3 | $235K | Sell |
6,475
-1,704
| -21% | -$61.8K | 0.01% | 490 |
|
|
2023
Q2 | $292K | Sell |
8,179
-320
| -4% | -$11.4K | 0.02% | 445 |
|
|
2023
Q1 | $302K | Sell |
8,499
-7
| -0.1% | -$249 | 0.03% | 420 |
|
|
2022
Q4 | $299K | Buy |
+8,506
| New | +$299K | 0.03% | 414 |
|
|
2022
Q3 | – | Sell |
-9,298
| Closed | -$506K | – | 523 |
|
|
2022
Q2 | $506K | Buy |
9,298
+3,252
| +54% | +$177K | 0.04% | 344 |
|
|
2022
Q1 | $329K | Hold |
6,046
| – | – | 0.04% | 297 |
|
|
2021
Q4 | $333K | Buy |
6,046
+320
| +6% | +$17.6K | 0.04% | 303 |
|
|
2021
Q3 | $274K | Buy |
5,726
+467
| +9% | +$22.3K | 0.03% | 325 |
|
|
2021
Q2 | $262K | Buy |
+5,259
| New | +$262K | 0.03% | 322 |
|
|
2019
Q3 | – | Sell |
-1,040
| Closed | -$520 | – | 300 |
|
|
2019
Q2 | $520 | Buy |
+1,040
| New | +$520 | 0.02% | 365 |
|